TELA · NASDAQ
TELA Bio (TELA) Stock Price & Fundamentals
TELA Bio (TELA) closed at $836.67 on Oct 9, 2026, up 0.53% from the previous close of $832.30.
Share price, past year
1Y +15.37%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $836.67 |
| Sep 30, 2026 | $806.58 |
| Aug 31, 2026 | $802.76 |
| Jul 31, 2026 | $791.87 |
| Jun 30, 2026 | $791.51 |
| May 29, 2026 | $773.69 |
| Apr 30, 2026 | $765.54 |
| Mar 31, 2026 | $846.92 |
| Feb 27, 2026 | $766.30 |
| Jan 30, 2026 | $801.01 |
| Dec 31, 2025 | $729.63 |
| Nov 28, 2025 | $716.33 |
| Oct 31, 2025 | $713.43 |
Key statistics
- Market cap
- $37.51B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.77
- Revenue (TTM)
- $79.91M
- Net income (TTM)
- −$41.18M
- Shares outstanding
- 44.8M
- Dividend yield
- —
- 52-week range
- $709.91 – $848.37
TELA Bio's market cap is $37.51B, based on a share price of $836.67 and 44.8M shares outstanding as of Jun 30, 2026.
Financials
TELA Bio reported revenue of $80.28M for fiscal 2025, up 15.84% from fiscal 2024.
TELA Bio reported a net loss of $38.83M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 9 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $80.28M | +15.8% | −$38.83M | −48.4% | −$0.83 | −$28.67M |
| FY2024ended Dec 31, 2024 | $69.30M | +18.6% | −$37.84M | −54.6% | −$1.33 | −$42.58M |
| FY2023ended Dec 31, 2023 | $58.45M | +41.1% | −$46.66M | −79.8% | −$2.04 | −$41.47M |
| FY2022ended Dec 31, 2022 | $41.42M | +40.6% | −$44.30M | −107.0% | −$2.72 | −$41.62M |
| FY2021ended Dec 31, 2021 | $29.46M | +61.8% | −$33.28M | −112.9% | −$2.30 | −$31.06M |
| FY2020ended Dec 31, 2020 | $18.21M | +17.9% | −$28.79M | −158.1% | −$2.23 | −$24.62M |
| FY2019ended Dec 31, 2019 | $15.45M | +86.7% | −$22.43M | −145.2% | −$17.10 | −$25.72M |
| FY2018ended Dec 31, 2018 | $8.27M | +94.9% | −$21.09M | −254.9% | −$101.41 | −$19.99M |
| FY2017ended Dec 31, 2017 | $4.25M | — | −$21.33M | −502.6% | — | −$16.48M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $19.29M | −$11.26M | −$0.20 |
| Q1 FY2026ended Mar 31, 2026 | $19.06M | −$12.27M | −$0.21 |
| Q4 FY2025ended Dec 31, 2025 | $20.87M | −$9.04M | −$0.17 |
| Q3 FY2025ended Sep 30, 2025 | $20.69M | −$8.60M | −$0.19 |
| Q2 FY2025ended Jun 30, 2025 | $20.20M | −$9.92M | −$0.22 |
| Q1 FY2025ended Mar 31, 2025 | $18.52M | −$11.26M | −$0.25 |
| Q4 FY2024ended Dec 31, 2024 | $17.65M | −$9.21M | −$0.17 |
| Q3 FY2024ended Sep 30, 2024 | $18.96M | −$10.37M | −$0.42 |
Company profile
- Name
- TELA Bio, Inc.
- Ticker
- TELA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 1 Great Valley Parkway, Suite 24, Malvern, PA 19355
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001561921
Recent SEC filings
- Oct 8, 2026
- Oct 6, 2026
- Oct 5, 2026
- Sep 29, 2026
- Sep 18, 2026
- Aug 31, 2026
- Aug 11, 2026
- Aug 10, 2026
Frequently asked questions
What is TELA Bio's stock price?
TELA Bio (TELA) closed at $836.67 on Oct 9, 2026, up 0.53% from the previous close of $832.30.
What is TELA Bio's market cap?
TELA Bio's market cap is $37.51B, based on a share price of $836.67 and 44.8M shares outstanding as of Jun 30, 2026.
How much revenue does TELA Bio make?
TELA Bio reported revenue of $80.28M for fiscal 2025, up 15.84% from fiscal 2024.
Does TELA Bio pay a dividend?
TELA Bio's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from TELA Bio, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures